Session » Osteoarthritis - Clinical Aspects Poster I: Treatments and Metabolic Risk Factors

Date: Sunday, November 8, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 314

A Double-Blind, Randomized, Controlled, Four Parallel Arm, Dose-Finding Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Single Intra-Articular (IA) Injections of Fasitibant in Patients with Symptomatic OA of the Knee

9:00AM-11:00AM: Abstract Number: 324

Activity Limitations in Persons with Low, Medium, and High Levels of Pain Prior to Total Knee Replacement: Implications for Appropriateness and Efficacy

9:00AM-11:00AM: Abstract Number: 332

Adipokine SERUM Levels in Patients with EARLY Knee Osteoarthritis with and without Metabolic Syndrome

9:00AM-11:00AM: Abstract Number: 331

Are Metabolic Factors Associated with Shoulder Osteoarthritis? a Multicentric Study.

9:00AM-11:00AM: Abstract Number: 328

Associations Between Body Composition Measures of Obesity and Radiographic Osteoarthritis in Older Adults: Data from the Dong-Gu Study

9:00AM-11:00AM: Abstract Number: 325

Best Performing Definition of Accelerated Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 330

Calf Muscle Adiposity Is Associated with Impaired Physical Performance in Knee OA

9:00AM-11:00AM: Abstract Number: 311

Comparison Between Intra Articular Ozone and Placebo in the Treatment of Knee Osteoarthritis: A Multicentric, Comparative, Randomized and Double-Blinded Clinical Trial

9:00AM-11:00AM: Abstract Number: 341

Construct Validity of Four Hand Mobility Measures in Hand Osteoarthritis (HOA)

9:00AM-11:00AM: Abstract Number: 337

Construct Validity of the Doyle Index in the Outcome Domain of Joint Activity in Hand Osteoarthritis Patients

9:00AM-11:00AM: Abstract Number: 318

Dual Variable Domain-Immunoglobulin (Dvd-Igâ„¢) Abt-981 Simultaneously and Dose-Dependently Inhibits Interleukin-1 Î‘lpha and -1 Î’eta in Subjects with Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 316

Effect of Vitamin D on Effusion-Synovitis in Knee Osteoarthritis: a Randomized Controlled Trial

9:00AM-11:00AM: Abstract Number: 320

Effectiveness of Bracing in Elderly with Knee Osteoartritis: A Randomized Controlled Trial

9:00AM-11:00AM: Abstract Number: 321

Effects of Bariatric Surgery on Long-Term Quality of Life Outcomes for Obese Patients with Osteoarthritis

9:00AM-11:00AM: Abstract Number: 310

Hyaluronic Acid Injections in Knee Osteoarthritis Patients Are Associated with Delay to Knee Arthroplasty

9:00AM-11:00AM: Abstract Number: 336

Lack of Uniform Diagnostic Criteria for Erosive OA: A Systematic Review

9:00AM-11:00AM: Abstract Number: 334

Lifetime Risk of Symptomatic Hand Osteoarthritis: The Johnston County Osteoarthritis Project

9:00AM-11:00AM: Abstract Number: 313

Magnetic Resonance Imaging Outcomes Using an Intra-Articular Injection (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study

9:00AM-11:00AM: Abstract Number: 339

More Inflammatory Signs on Ultrasound, Severe Pain and Stiffness Are Associated with Erosive Than Non-Erosive Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 326

Older Adults without Extreme Obesity Are at Highest Risk for Accelerated Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 323

Perioperative Interventions for Smoking Cessation in Hip and Knee Arthroplasty for Osteoarthritis and Other Non-Traumatic Diseases

9:00AM-11:00AM: Abstract Number: 319

Phase 1 Studies of Anti-Interleukin-1 Dual-Variable Domain Immunoglobulin in Healthy Subjects and Patients with Osteoarthritis

9:00AM-11:00AM: Abstract Number: 335

Prevalence of Hand Osteoarthritis and Factors Associated with Pain in Korean Farmers

9:00AM-11:00AM: Abstract Number: 340

Radiographic Assessment of Hand Osteoarthritis – the Role of Oblique View Images

9:00AM-11:00AM: Abstract Number: 322

Reduction of Treatment Needed for Knee Osteoarthritis after Bariatric Surgery

9:00AM-11:00AM: Abstract Number: 317

Relation of Incident Bisphosphonate Use to Trajectory of Joint-Space Width

9:00AM-11:00AM: Abstract Number: 312

Safety, Efficacy and Biomarker Outcomes of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

9:00AM-11:00AM: Abstract Number: 329

Serum Leptin and Risk of Knee Pain and Osteoarthritis: Multicenter Osteoarthritis Study

9:00AM-11:00AM: Abstract Number: 338

Smoking and Alcohol Use Are Associated with Structural and Inflammatory Hand Osteoarthritis Features in a Population Based Study

9:00AM-11:00AM: Abstract Number: 333

Smoking and Knee and Hip Osteoarthritis Evolution. Results from the Knee and Hip Osteoarthritis Long-Terme Assessment Cohort

9:00AM-11:00AM: Abstract Number: 315

Structural Effects of Sprifermin in Knee Osteoarthritis: A Post-Hoc Analysis on Cartilage and Non-Cartilaginous Tissue Alterations

9:00AM-11:00AM: Abstract Number: 342

The Effect of Erosive Status on Systemic Inflammatory Biomarkers in Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 327

The Relation of Plasma Vitamin K Status to Meniscal Pathology in Knee Osteoarthritis: The Multicenter Osteoarthritis Study

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].